Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19)
Irina Kislaya(German Center for Infection Research), Paulo Gonçalves(National Institute of Health Dr. Ricardo Jorge), Rita Matos(Universidade do Porto), Ana Paula Rodrigues(Microsoft (Brazil)), Rita de Sousa(Instituto Nacional de Saúde), Marta Barreto(Administração Regional de Saúde de Lisboa e Vale do Tejo), Ana Cristina Garcia(Instituto Nacional de Saúde), Raquel Guiomar
Cited by 38
Related Papers
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study
|Eurosurveillance|2013|198
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century
|PLoS ONE|2019|185
Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study
|The Lancet Infectious Diseases|2019|156